 I think that they have overspent on R&D. I mean, if you compare, if you look at it, it's really fascinating. So we know looking over the last 25 years that the bulk of innovation in the pharmaceutical arena has come from smaller biotech companies, right, who are spending over the course of developing their products a fraction of what the big companies are spending.